Methodological issues in the assessment of cognitive decline in ONTARGET and TRANSCEND

The Lancet Neurology

Volumn 10, Issue 1, 2011, Pages 22-24

  Odili, Augustine N ^a,b   Richart, Tom ^a,c   Staessen, Jan A ^a,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF ABUJA   (Nigeria)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM ION; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO; RAMIPRIL; TELMISARTAN;

ALZHEIMER DISEASE; ANTIHYPERTENSIVE THERAPY; ATTENTION; BLOOD PRESSURE REGULATION; COGNITION; COGNITIVE DEFECT; DEMENTIA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFECT; HUMAN; HYPERTENSION; MEMORY; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROPROTECTION; NOTE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; DOUBLE-BLIND METHOD; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 78650016110     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70272-6     Document Type: Note

References (14)

1. Anderson C, Teo K, Gao P, et al. Renin-angiotensin system blockade and cognitive function in patients at high risk of cardiovascular disease: analysis of data from the ONTARGET and TRANSCEND studies. Lancet Neurol 2010, for the ONTARGET and TRANSCEND Investigators, published online October 27. 10.1016/S1474-4422(10)70250-7.
2. Staessen JA, Richart T, Birkenhäger WH Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension 2007, 49:389-400.
3. Ferri CP, Prince M, Brayne C, et al. Global prevalence of dementia: a Delphi consensus study. Lancet 2005, 366:2112-2117. for Alzheimer's Disease International.
4. Forette F, Seux ML, Staessen JA, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998, 352:1347-1351. on behalf of the Syst-Eur Investigators.
5. Peters R, Beckett N, Forette F, et al. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial. Lancet Neurol 2008, 7:683-689. for the HYVET investigators.
6. Zhang H, Thijs L, Staessen JA Blood pressure lowering for the primary and secondary prevention of stroke. Hypertension 2006, 48:187-195.
7. Liu L, Wang Z, Gong L, et al. Blood pressure lowering for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. Hypertens Res 2009, 32:1032-1040.
8. Messerli FH, Grossman E, Lever AF Do thiazide diuretics confer specific protection against strokes?. Arch Intern Med 2003, 163:2557-2560.
9. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 2003, 362:1527-1535. Blood Pressure Lowering Treatment Trialists' Collaboration.
10. Verdecchia P, Reboldi G, Angeli A, et al. Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention. Hypertension 2005, 46:386-392.
11. Fournier A, Oprisiu R, Andrejak M, Godefroy O, Rosa A, Achard JM Age-adjusted stroke incidence increase: could angiotensin AT1 receptor antagonists enhance stroke prevention?. Stroke 2002, 33:881-882.
12. Hanon O, Latour F, Seux ML, et al. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French cohort (REAL.FR). J Nutr Health Aging 2005, 9:106-111.
13. Farmer ME, White LR, Abbott RD, et al. Blood pressure and cognitive performance: the Framingham study. Am J Epidemiol 1987, 126:1103-1114.
14. Elias MF, Wolf PA, D'Agostino RB, Cobb J, White LR Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 1993, 138:353-364.